Japan Active Pharmaceutical Ingredients Market Report by Drug Type, Type of Manufacturer, Type of Synthesis, Therapeutic Application, and Region 2025-2033
일본의 원료의약품(API) 시장 규모는 2024년 279억 달러로 추정됩니다. 향후 IMARC 그룹은 2033년에는 432억 달러에 달할 것으로 예상하며, 2025년부터 2033년까지 5%의 연평균 성장률(CAGR)을 보일 것으로 예측했습니다. 바이오시밀러 및 제네릭 의약품에 대한 수요 증가와 임상시험 증가가 시장 성장의 주요 원동력이 되고 있습니다.
본 보고서에서 다룬 주요 질문
- 일본 원료의약품(API) 시장은 지금까지 어떻게 발전해 왔으며, 향후 몇 년동안 어떻게 발전할 것인가?
- 코로나19가 일본 원료의약품(API) 시장에 미치는 영향은?
- 일본 원료의약품(API) 시장의 약품 유형별 분류는?
- 일본 원료의약품(API) 시장의 제조업체 유형별 분류는?
- 일본 원료의약품(API) 시장의 합성 유형별 구성비는?
- 일본 원료의약품(API) 시장의 치료용도별 시장 현황은?
- 일본 원료의약품(API) 시장 가치사슬의 다양한 단계는?
- 일본 원료의약품(API) 시장의 주요 촉진요인과 과제는?
- 일본 원료의약품(API) 시장 구조와 주요 기업은?
- 일본 원료의약품(API) 시장 경쟁 구도은?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 일본의 원료의약품(API) 시장 : 서론
제5장 일본의 원료의약품(API) 시장 구도
- 과거 및 현재 시장 동향(2019-2024년)
- 시장 예측(2025-2033년)
제6장 일본의 원료의약품(API) 시장 : 의약품 유형 내역
- 혁신적 원료의약품(API)
- 제네릭 원료의약품(API)
제7장 일본의 원료의약품(API) 시장 : 제조업체 유형별 분석
제8장 일본의 원료의약품(API) 시장 : 합성 유형별 분석
- 합성 원료의약품(API)
- 바이오테크놀러지 원료의약품(API)
제9장 일본의 원료의약품(API) 시장 : 치료 용도별 분석
- 종양학
- 심장혈관 및 호흡기
- 당뇨병
- 중추신경계 질환
- 신경질환
- 기타
제10장 일본의 원료의약품(API) 시장 : 경쟁 구도
- 개요
- 시장 구조
- 시장 기업 포지셔닝
- 주요 성공 전략
- 경쟁 대시보드
- 기업 평가 상한
제11장 주요 기업 개요
제12장 일본의 원료의약품(API) 시장 : 업계 분석
- 성장 촉진요인 및 억제요인과 기회
- Porter의 Five Forces 분석
- 밸류체인 분석
제13장 부록
LSH
Japan active pharmaceutical ingredients (API) market size reached USD 27.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 43.2 Billion by 2033, exhibiting a growth rate (CAGR) of 5% during 2025-2033. The increasing need for biosimilars and generic drugs, coupled with the growing number of clinical trials, is primarily driving the market growth.
Active pharmaceutical ingredients (APIs) are essential components of medications, ensuring they deliver the desired healing outcomes. These biologically active compounds are vital in treating and managing symptoms of numerous health issues. They are crafted through intricate chemical and biological methodologies, with their purity, strength, and consistency being critical for their medicinal efficacy. APIs enable specific treatments for a wide range of illnesses, allowing pharmaceutical companies to create drugs tailored to specific diseases and populations. They are incorporated in various drug formats, such as pills, capsules, creams, or injections, each with unique manufacturing needs. In line with this, active pharmaceutical ingredients contribute to the progression of drug delivery techniques, enhancing the efficient and safe dispersion of drugs within the human body.
Japan Active Pharmaceutical Ingredients (API) Market Trends:
The active pharmaceutical ingredients market in Japan is witnessing substantial growth, driven predominantly by the exponential progression in its pharmaceutical domain. As Japan grapples with a rising prevalence of various chronic ailments, there's a heightened demand for APIs, mirroring emerging trends. A notable factor propelling this market trajectory in Japan is the intensive research and development endeavors by its pharmaceutical giants. Additionally, their quest to launch enhanced product iterations, especially high-potency active pharmaceutical ingredients, paints an optimistic picture for the nation's API market. Besides this, the unprecedented strides taken by the Japanese pharmaceutical sector during global health crises further amplify this market's momentum. Concurrently, Japan, being a hotspot of technological evolution, is experiencing breakthroughs in biotechnology and life sciences, factors that are auspiciously shaping its API landscape. An augmented count of research institutions and the uptick in clinical explorations signify the growth potential. Compounded by the rapid urban sprawl, Japan's burgeoning elderly demographic, and substantial investments by both governmental and private entities towards refining the healthcare infrastructure, it's evident that Japan's active pharmaceutical ingredients market is poised for sustained growth in the foreseeable future.
Japan Active Pharmaceutical Ingredients (API) Market Segmentation:
Drug Type Insights:
- Innovative Active Pharmaceutical Ingredients (API)
- Generic Active Pharmaceutical Ingredients (API)
Type of Manufacturer Insights:
- Captive Manufacturers
- Merchant API Manufacturers
- Innovative Merchant API Manufacturers
- Generic Merchant API Manufacturers
Type of Synthesis Insights:
- Synthetic Active Pharmaceutical Ingredients (API)
- Type
- Innovative Synthetic APIs
- Generic Synthetic APIs
- Biotech Active Pharmaceutical Ingredients (API)
- Type
- Innovative Biotech APIs
- Biosimilars
- Product
- Monoclonal Antibodies
- Vaccines
- Cytokines
- Fusion Proteins
- Therapeutic Enzymes
- Blood Factors
- Expression System
- Mammalian Expression Systems
- Microbial Expression Systems
- Yeast Expression Systems
- Transgenic Animal Systems
- Others
Therapeutic Application Insights:
- Oncology
- Cardiovascular and Respiratory
- Diabetes
- Central Nervous System Disorders
- Neurological Disorders
- Others
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan active pharmaceutical ingredients (API) market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan active pharmaceutical ingredients (API) market?
- What is the breakup of the Japan active pharmaceutical ingredients (API) market on the basis of drug type?
- What is the breakup of the Japan active pharmaceutical ingredients (API) market on the basis of type of manufacturer?
- What is the breakup of the Japan active pharmaceutical ingredients (API) market on the basis of type of synthesis?
- What is the breakup of the Japan active pharmaceutical ingredients (API) market on the basis of therapeutic application?
- What are the various stages in the value chain of the Japan active pharmaceutical ingredients (API) market?
- What are the key driving factors and challenges in the Japan active pharmaceutical ingredients (API)?
- What is the structure of the Japan active pharmaceutical ingredients (API) market and who are the key players?
- What is the degree of competition in the Japan active pharmaceutical ingredients (API) market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Active Pharmaceutical Ingredients (API) Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Active Pharmaceutical Ingredients (API) Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan Active Pharmaceutical Ingredients (API) Market - Breakup by Drug Type
- 6.1 Innovative Active Pharmaceutical Ingredients (API)
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
- 6.2 Generic Active Pharmaceutical Ingredients (API)
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
7 Japan Active Pharmaceutical Ingredients (API) Market - Breakup by Type of Manufacturer
- 7.1 Captive Manufacturers
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
- 7.2 Merchant API Manufacturers
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Segmentation
- 7.2.3.1 Innovative Merchant API Manufacturers
- 7.2.3.2 Generic Merchant API Manufacturers
- 7.2.4 Market Forecast (2025-2033)
8 Japan Active Pharmaceutical Ingredients (API) Market - Breakup by Type of Synthesis
- 8.1 Synthetic Active Pharmaceutical Ingredients (API)
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Segmentation
- 8.1.3.1 Type
- 8.1.3.1.1 Innovative Synthetic APIs
- 8.1.3.1.2 Generic Synthetic APIs
- 8.1.4 Market Forecast (2025-2033)
- 8.2 Biotech Active Pharmaceutical Ingredients (API)
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Segmentation
- 8.2.3.1 Type
- 8.2.3.1.1 Innovative Biotech APIs
- 8.2.3.1.2 Biosimilars
- 8.2.3.2 Product
- 8.2.3.2.1 Monoclonal Antibodies
- 8.2.3.2.2 Vaccines
- 8.2.3.2.3 Cytokines
- 8.2.3.2.4 Fusion Proteins
- 8.2.3.2.5 Therapeutic Enzymes
- 8.2.3.2.6 Blood Factors
- 8.2.3.3 Expression System
- 8.2.3.3.1 Mammalian Expression Systems
- 8.2.3.3.2 Microbial Expression Systems
- 8.2.3.3.3 Yeast Expression Systems
- 8.2.3.3.4 Transgenic Animal Systems
- 8.2.3.3.5 Others
- 8.2.4 Market Forecast (2025-2033)
9 Japan Active Pharmaceutical Ingredients (API) Market - Breakup by Therapeutic Application
- 9.1 Oncology
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
- 9.2 Cardiovascular and Respiratory
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
- 9.3 Diabetes
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
- 9.4 Central Nervous System Disorders
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2019-2024)
- 9.4.3 Market Forecast (2025-2033)
- 9.5 Neurological Disorders
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2019-2024)
- 9.5.3 Market Forecast (2025-2033)
- 9.6 Others
- 9.6.1 Historical and Current Market Trends (2019-2024)
- 9.6.2 Market Forecast (2025-2033)
10 Japan Active Pharmaceutical Ingredients (API) Market - Competitive Landscape
- 10.1 Overview
- 10.2 Market Structure
- 10.3 Market Player Positioning
- 10.4 Top Winning Strategies
- 10.5 Competitive Dashboard
- 10.6 Company Evaluation Quadrant
11 Profiles of Key Players
- 11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
- 11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
- 11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
- 11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
- 11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events
12 Japan Active Pharmaceutical Ingredients (API) Market - Industry Analysis
- 12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
- 12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
- 12.3 Value Chain Analysis
13 Appendix
